IL2 and renal cell carcinoma: Historically, PBMC were cultured with IL-2 for a few days and then infused into the patient (with renal cell carcinoma or metastatic melanoma) together with high dose IL-2 that provoked huge side effects such as a serious vascular leak syndrome.